Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Antiprogestational agents available from the NIH

Oct. 31, 1997

NIAID researchers report advances in gene therapy for CGD

Oct. 30, 1997

Niemann-Pick Type C disease-related technology available for licensing from NIH

Oct. 30, 1997

Beta3-adrenoceptor agonists reported by Asahi Chemical

Oct. 30, 1997

Pravachol now available in Canada for preventing a first heart attack

Oct. 29, 1997

New ACAT inhibitors discovered at Mitsubishi Chemical

Oct. 29, 1997

FDA clears generic estradiol product

Oct. 29, 1997

Shaman issued U.S. patent for antidiabetic compounds

Oct. 28, 1997

Watson acquires Searle contraceptive products

Oct. 27, 1997

New antidiabetic agents from Boehringer Mannheim

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...